Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway
- 30 April 2024
- journal article
- research article
- Published by Elsevier in Journal of Proteomics
- Vol. 301, 105182
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Calpains for dummies: What you need to know about the calpain familyBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2021
- Effects of functionally diverse calpain system on immune cellsImmunologic Research, 2021
- Therapeutic resistance of pancreatic cancer: Roadmap to its reversalBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- The Complexity of Targeting Chemokines to Promote a Tumor Immune ResponseInflammation, 2020
- Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapyCancer Letters, 2020
- High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patientsClinical and Translational Oncology, 2018
- Evidence for calpains in cancer metastasisJournal of Cellular Physiology, 2018
- Calpains — An elaborate proteolytic systemBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012
- CAPN 8: Isolation of a New Mouse Calpain-IsoenzymeBiochemical and Biophysical Research Communications, 1999
- Expression of calpain I messenger RNA in human renal cell carcinoma: Correlation with lymph node metastasis and histological typeInternational Journal of Cancer, 1999